NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Probiotic Use for Recovery Enhancement From Long COVID-19

CompletedPhase 2

Sponsor: Rush University Medical Center

Conditions: Post-Acute COVID-19 Syndrome

Interventions: Probiotic Agent, Placebo

Countries: United States

The goal of this clinical trial is to learn if probiotics can improve symptoms and quality of life in participants with Long COVID.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Age ≥18 years who report Long COVID with persistent symptoms at the time of study initiation

Exclusion Criteria:

* No longer have symptoms consistent with LC
* Are unable to take the study medication daily
* Are currently pregnant or planning to become pregnant over the course of the study
* Are currently breastfeeding
* Have been diagnosed with an immune-compromising condition
* Are currently taking immunosuppressants
* Do not speak English as a primary language
* Are regularly taking probiotics
* Are enrolled in another Long COVID study with an intervention

Locations (1)

Chicago, Illinois, United States